Altogether, our results indicate that inhibiting PTPN1 through treatment with the PTPN1/2 inhibitor K884 restores activation of STAT3 and promotes myogenic differentiation of DMD MuSCs. Here, PTPN1 is linked to Duchenne muscular dystrophy.